Extracellular vesicles for cardiovascular therapeutics
In this landmark review, group da Costa Martins and collaborators outline the endogenous properties of EVs that make them natural delivery agents as well as the features that can be improved by bioengineering.
We also discuss the therapeutic applications of native and bioengineered EVs to cardiovascular diseases and examine the opportunities and challenges that need to be addressed to advance this research area, with an emphasis on clinical translation.
Extracellular vesicles are a heterogeneous group of natural particles that are relevant to the treatment of cardiovascular diseases. These endogenous vesicles have certain properties that allow them to survive in the extracellular space, bypass biological barriers and deliver their biologically active molecular cargo to recipient cells. Moreover, EVs can be bioengineered to increase their stability, bioactivity, presentation to acceptor cells and capacity for on-target binding at both cell-type-specific and tissue-specific levels.
Also read
-
Count your cards and do your maths!
By designing a card game, maths tutors at the Department of Advanced Computing Sciences increase their student’s engagement with linear algebra.
-
25 million euros for expansion ETPathfinder Maastricht
The Dutch government is allocating 25 million euros for the proposed expansion of ETPathfinder in Maastricht. The expansion aims to transform the existing gravitational wave detection research facility in Limburg into a center for technology validation, integration, and training in Europe.
-
FSE STEM Career Day 2026: a record-breaking edition
With nearly 750 registered students and 35 companies in attendance, the FSE STEM Career Day 2026 was the largest and most successful edition to date. Participation surged by an impressive 50% compared to last year, a clear sign that both STEM talent and employers are eager to connect.
